Glenmark Pharmaceuticals informs about media release

24 Jan 2019 Evaluate

Glenmark Pharmaceuticals has informed about submission of a media release titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Topiramate Extended? Release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg’,  which is self explanatory. 

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1079.55 8.25 (0.77%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.